Essentials: Compulsive Behaviors & Deep Brain Stimulation | Dr. Casey Halpern

Source description
In this Huberman Lab Essentials episode, my guest is Dr. Casey Halpern, MD, a professor of neurosurgery at the Perelman School of Medicine at the University of Pennsylvania. We discuss how deep brain stimulation and other neuromodulation approaches are being used to treat …

In this Huberman Lab Essentials episode, my guest is Dr. Casey Halpern, MD, a professor of neurosurgery at the Perelman School of Medicine at the University of Pennsylvania. We discuss how deep brain stimulation and other neuromodulation approaches are being used to treat Parkinson's disease, obsessive-compulsive disorder (OCD), binge eating disorder and depression-related symptoms. We also explore the brain circuits that drive compulsions, cravings and impulsivity, as well as emerging non-invasive tools for predicting and treating harmful behaviors. Read the episode show notes at hubermanlab.com. Thank you to our sponsors AG1: https://drinkag1.com/huberman Function: https://functionhealth.com/huberman Rorra: https://rorra.com.huberman

2026-05-07 38m 06s Source
Key Topics
  1. Neurosurgery scope and subspecialization
  2. Deep brain stimulation basics
  3. Side effects as circuit clues
  4. Psychiatric improvements during movement DBS
  5. OCD as a spectrum and when it becomes a disorder
  6. First-line OCD treatments and limits
  7. Treatment-refractory OCD and surgical options
  8. DBS versus capsulotomy ablation tradeoffs
  9. Typical response rates and unmet need
  10. OCD circuit framing: cortex to basal ganglia
  11. Ventral striatum and nucleus accumbens in compulsions
  12. “Urge despite risk” as a shared mechanism
  13. Nucleus accumbens functions in health and pathology
  14. Finding symptom-specific signals during surgery
  15. Why “craving” is a practical clinical construct
  16. Proof-of-concept obsession cells in OCD
  17. Non-invasive brain stimulation: promise and imprecision
  18. TMS current clinical role and as a circuit probe
  19. Focused ultrasound today and future directions
  20. Limits of ultrasound for psychiatric disease
  21. Stereo-EEG as a model for psychiatric circuit mapping
  22. Toward invasive-to-noninvasive translation
  23. Why obesity and binge eating may be more tractable initially
  24. Awareness as a tool and where it fails
  25. Closed-loop detection of craving-related signals
  26. Laboratory mood provocation to elicit binges
  27. Why CBT can require ongoing reinforcement
  28. AI and wearables for early warning of episodes
  29. Compulsion versus impulsivity distinctions
  30. Scalability and the role of neurosurgery in public health
These summaries are AI-generated and may contain inaccuracies. If in doubt, please verify the information with the original source.

Neurosurgery scope and subspecialization

Halpern explains what neurosurgeons treat across brain, spine, and peripheral nerves. He describes modern subspecialization and his focus in stereotactic functional neurosurgery.

Deep brain stimulation basics

DBS involves implanting thin insulated leads into specific brain targets. Therapy comes from delivering adjustable electrical stimulation through tiny contacts to modulate local circuits.

Side effects as circuit clues

Stimulating nearby regions can briefly trigger laughter, panic, or other emotional states. Those transient effects can reveal therapeutic targets for mood and compulsive symptoms.

Psychiatric improvements during movement DBS

Some Parkinson’s patients report reduced gambling, improved mood, or less compulsivity after DBS for tremor. This suggests motor targets can intersect with limbic and reward circuitry.

OCD as a spectrum and when it becomes a disorder

He frames obsessionality and compulsivity as traits that can be adaptive when controlled. OCD is when obsessions and compulsions become intrusive, uncontrollable, and impairing.

First-line OCD treatments and limits

SSRIs and certain tricyclics are common medication approaches targeting serotonin-related systems. Exposure and response prevention is highlighted as highly effective but not sufficient for all patients.

Treatment-refractory OCD and surgical options

A subset of patients remains severely symptomatic despite meds and therapy. For them, DBS or lesion procedures like capsulotomy may be considered with careful risk-benefit counseling.

DBS versus capsulotomy ablation tradeoffs

DBS is adjustable and reversible in effect, while ablation destroys a small brain region. He notes ablations can help with few obvious side effects but remain irreversible surgery.

Typical response rates and unmet need

He cites responder rates around 50% for current surgical approaches, with many responders still symptomatic. This motivates more symptom-specific targeting and personalized circuit approaches.

OCD circuit framing: cortex to basal ganglia

He describes hyperfunctioning prefrontal and orbitofrontal cortex with projections into basal ganglia circuits. The ventral striatum becomes a key node for compulsive behavior gating.

Ventral striatum and nucleus accumbens in compulsions

The ventral striatum, including nucleus accumbens, is discussed as central to reward seeking and compulsion. Disruption can shift behavior toward pursuing reward despite punishment.

“Urge despite risk” as a shared mechanism

He links OCD, addiction, and some eating disorders through persistent urges that override judgment and safety. This common denominator guides target selection and translational research.

Nucleus accumbens functions in health and pathology

Nucleus accumbens is positioned as an integrative reward circuit hub. Pathology arises when strong repeated rewards or stressors hijack normal control and amplify maladaptive urges.

Finding symptom-specific signals during surgery

In Parkinson’s, surgeons can detect tremor-related neural patterns to guide placement. Halpern aims to find analogous “craving” or “obsession” signals to improve psychiatric targeting.

Why “craving” is a practical clinical construct

He prefers the term craving because patients recognize and report it reliably. It can be more accessible than labels like loss of control or binge behavior for some individuals.

Proof-of-concept obsession cells in OCD

He describes a single-case effort to identify neural activity linked to obsessions intraoperatively. The goal is to optimize electrode placement by anchoring to disease-relevant physiology.

Non-invasive brain stimulation: promise and imprecision

Halpern argues non-invasive approaches should be embraced but made more precise. He notes mechanisms are often unclear, similar to ongoing uncertainty about DBS mechanisms.

TMS current clinical role and as a circuit probe

He notes TMS is FDA-approved for depression, OCD, and nicotine addiction. TMS may help define circuits and identify candidates who could benefit from invasive trials if effects are temporary.

Focused ultrasound today and future directions

MRI-guided focused ultrasound is described as an FDA-approved non-invasive ablation for tremor. Research is exploring modulation without lesioning and opening the blood-brain barrier for targeted delivery.

Limits of ultrasound for psychiatric disease

He emphasizes the main barrier is not the tool but target uncertainty. Without knowing the right circuit node, psychiatric ultrasound ablation may only replicate older targets and outcomes.

Stereo-EEG as a model for psychiatric circuit mapping

He describes modern stereoencephalography in epilepsy as safe and informative for locating seizure networks. Similar invasive recordings could map psychiatric circuits and improve targeting strategies.

Toward invasive-to-noninvasive translation

He outlines a pathway where invasive recordings define reliable targets first. Those pooled data could later support non-invasive targets for ultrasound or other modalities.

Why obesity and binge eating may be more tractable initially

He suggests preclinical models can capture aspects of binge and obesity better than some psychiatric syndromes. This supports earlier target development for DBS in those conditions compared to others.

Awareness as a tool and where it fails

Both discuss whether better interoception and state awareness can prevent episodes. Halpern notes the most severe patients can be highly aware yet still lose control, implying a deeper circuit failure.

Closed-loop detection of craving-related signals

He describes implanted devices that record population activity to detect states linked to cravings. The aim is to trigger stimulation at home when patterns indicate elevated risk of binge behavior.

Laboratory mood provocation to elicit binges

A validated mood provocation protocol is used to induce patient-specific emotional states tied to binge episodes. Brain signals are synchronized with video and eye tracking to capture pre-bite dynamics.

Why CBT can require ongoing reinforcement

He praises cognitive behavioral approaches while noting relapse can occur when therapy stops. Some patients need sustained intervention to maintain behavior change.

AI and wearables for early warning of episodes

They discuss machine learning using voice, physiology, sleep, and breathing to predict depressive or impulsive episodes before conscious awareness. Halpern argues invasive understanding will sharpen what to look for non-invasively.

Compulsion versus impulsivity distinctions

Halpern differentiates compulsion as persistent urge despite risk from impulsivity as failure to wait or inhibit action. He connects both to public health concerns like suicidality and addiction.

Scalability and the role of neurosurgery in public health

He acknowledges surgery cannot scale to tens of millions affected by obesity, depression, and addiction. He positions neurosurgical research as a way to rigorously define mechanisms and inspire scalable therapies.